US Patent 11198679 Method of treating or preventing Ras-mediated diseases

Patent 11198679 was granted and assigned to ADT Pharmaceuticals, LLC on December, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

‌

ADT Pharmaceuticals, LLC

Current Assignee

‌

ADT Pharmaceuticals, LLC

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11198679

Date of Patent

December 14, 2021

Patent Application Number

16837757

Date Filed

April 1, 2020

Patent Citations Received

‌

US Patent 11407727 Indenyl compounds, pharmaceutical compositions, and medical uses thereof

‌

US Patent 11680073 Anticancer indenes, indanes, azaindenes, azaindanes, pharmaceutical compositions and uses

Patent Primary Examiner

‌

Timothy P Thomas

Patent abstract

Disclosed are compounds, for example, a compound of formula I,

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11198679 Method of treating or preventing Ras-mediated diseases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API